Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
INO
#3996
Inovio Pharmaceuticals, Inc. - Common Stock
1.1
7
USD
+0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.86%
Monthly Change
+4.46%
6 month change
-29.52%
Year Change
-14.60%
Previous Close
1.1
6
Open
1.1
8
Low
1.1
5
High
1.1
9
Volume
422
Markets
US Stock Market
Healthcare
Biotechnology
INO
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
17.3 M
18.12 M
21.68 M
23.37 M
36.67 M
69.09 M
82.27 M
Valuation ratios
Enterprise value
1.59 B
1.01 B
349.07 M
160.63 M
1.29 M
75.95 M
72.13 M
Price to earnings ratio
—
-3.44
-1.3
-1.11
-0.46
-0.96
-0.76
Price to sales ratio
—
587.16
35.34
180.37
228.26
1 248.52
—
Price to cash flow ratio
—
-4.83
-1.68
-1.21
-0.48
-0.92
-0.71
Price to book ratio
—
2.61
1.63
1.28
0.73
3.39
1.01
Enterprise value to EBITDA ratio
-13.17
-3.41
-1.33
-1.14
-0.01
-0.89
-0.88
Profitability ratios
Return on assets %
-0.31
-0.61
-0.8
-0.79
-0.95
-1.14
-0.4
Return on equity %
-0.36
-0.76
-1.26
-1.15
-1.57
-3.53
-3.24
Return on invested capital %
-582.3
-1 396.45
-1 844.29
—
—
—
—
Gross margin %
100
100
100
100
100
100
—
Operating margin %
-1 674.25
-16.97 K
-2 607.35
-17.3 K
-51.62 K
-132.87 K
—
EBITDA margin %
-1 625.86
-16.77 K
-2 566.88
-16.97 K
-50.81 K
-130.7 K
—
Net margin %
-2 245.39
-17.11 K
-2 726.67
-16.24 K
-49.25 K
-130 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
11.3
6.82
3.25
3.6
2.77
1.4
1.04
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.02
0
0.02
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
0.1
—
—
—
Debt to equity ratio
—
—
—
0.14
—
—
—
Long term debt to total assets ratio
—
—
—
0.1
0
—
—
Long term debt to total equity ratio
—
—
—
0.14
0
—
—
Per share metrics
Operating cash flow per share
—
-12.4
-10.87
-5.61
-3.83
-1.89
-1.68
EBIT per share
—
-17.31
-13.46
-6.49
-4.14
-1.85
-1.69
EBITDA per share
—
-17.1
-13.25
-6.37
-4.07
-1.82
-1.66
Total debt per share
—
—
—
0.76
—
—
—
Cash per share
—
23.06
12.72
6.55
3.46
1.25
0.55
Net current asset value per share
—
25.77
15.85
6.91
3.6
1.3
0.57
Tangible book value per share
—
22.97
11.18
5.29
2.52
0.51
0.09
Working capital per share
—
21.99
10.98
4.99
2.3
0.37
0.02
Book value per share
—
22.97
11.18
5.29
2.52
0.51
0.09
News
Inovio: All Eyes On INO-3107 As Binary FDA Decision Looms (NASDAQ:INO)
Inovio Pharmaceuticals, Inc. (INO) Q1 2026 Earnings Call Transcript
Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call - Inovio Pharmaceuticals (NASDAQ:INO)
ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth
Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up
RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
RARE Q1 Loss Wider Than Expected, Sales Down Y/Y on Seasonal Effect
NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up
Viatris Gears Up to Report Q1 Earnings: What's in the Cards?
Catalyst Pharmaceutics to Report Q1 Earnings: Is a Beat in the Cards?
Pacira Q1 Earnings Miss Estimates on Higher Costs, Revenues Rise Y/Y
Zoetis Gears Up to Report Q1 Earnings: Is a Beat in the Cards?